Anonymous
Guest
Anonymous
Guest
Ok..this company has lost it. Flector Patch...really. No doc uses it, but we must promote this garbage.
Ok..this company has lost it. Flector Patch...really. No doc uses it, but we must promote this garbage.
I believe the patent expires on the Lidoderm patch very soon. So, our patch will be even more difficult to sell. Can you say EXUBERA?
Patches are still systemic. They still have to be metabolized and are absorbed. Excelon patch still has tolerability issues for example. C'mon know it alls! People will like the patch in combo with other pain meds or for tolerability perception. There is a place for everything.
CV risk higher than Vioxx. Thud! Bump! Crash!!
You are a dummy. Read the PI.
I believe the patent expires on the Lidoderm patch very soon. So, our patch will be even more difficult to sell. Can you say EXUBERA?